87
Participants
Start Date
June 11, 1998
Primary Completion Date
September 26, 2001
Study Completion Date
February 10, 2009
dextromethorphan hydrobromide
morphine sulfate
Cross Cancer Institute, Edmonton
Newfoundland Cancer Treatment and Research Foundation, St. John's
Princess Margaret Hospital, Toronto
McGill University, Montreal
Lead Sponsor
NCIC Clinical Trials Group
NETWORK